Nautilus Biotechnology, Inc. (NAUT) Social Stream
Nautilus Biotechnology Inc (NAUT) Price Targets From Analysts
Use the tables below to see what analysts covering Nautilus Biotechnology Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
NAUT reports an average of 110.09% for its upside potential over the past 28 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NAUT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
NAUT's average broker recommendation rating improved by 0 over the prior 28 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- NAUT has a greater number of analysts covering the stock than 26.89% of all US stocks.
- Nautilus Biotechnology Inc's average analyst price target is greater than 29.58% of all US stocks.
- To contextualize these metrics, consider that out of Trading stocks, Nautilus Biotechnology Inc's upside potential (average analyst target price relative to current price) is higher than 294.58% of them.
- In the context of Trading stocks, Nautilus Biotechnology Inc's variance in analysts' estimates is lower than -44.5% of them.
What is the outlook for NAUT? Use POWR Ratings for clearer insight into price direction.